Role of environmental factors in the etiology of hepatocellular carcinoma;A környezeti tényezok szerepe a hepatocellularis carcinoma kialakulásában

Orvosi Hetilap

Volumn 151, Issue 28, 2010, Pages 1132-1136

  Tornai, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Alcohol; Hepatocellular carcinoma; Obesity; Oral contraceptives; Smoking

Indexed keywords

AFLATOXIN; ALCOHOL; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOTOXIN; ORAL CONTRACEPTIVE AGENT; ORGANIC SOLVENT; SELENIUM; SIMVASTATIN;

ALCOHOL CONSUMPTION; CHRONIC HEPATITIS; CIGARETTE SMOKING; COFFEE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PREVALENCE; REVIEW; RISK FACTOR;

EID: 77954005400     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28913     Document Type: Review

References (34)

1. Parkin, D. M.: Global cancer statistics in the year 2000. Lancet Oncol., 2001, 2, 533-543.
2. El-Serag, H. B., Rudolph, K. L.: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132, 2557-2576.
3. Fattovich, G., Stroffolini, T., Zagni, I. es mtsa: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 2004, 127, S53-S50.
4. El-Serag, H. B., Mason, A. C.: Risk factors for the rising rates of primary liver cancer in the United States. Arch. Int. Med., 2000, 160, 3227-3230.
5. Morgan, T. R., Mandayam, S., Jamal, M. M.: Alcohol and hepatocellular carcinoma. Gastroenterology, 2004, 127, S87-S96.
6. Hassan, M. M., Hwang, L. Y., Hatten, C. J. es mtsai: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 2002, 36, 1206-1213.
7. Poschl, G., Seitz, H. K.: Alcohol and cancer. Alcohol & Alcoholism, 2004, 39, 155-165.
8. Donato, F., Tagger, A., Gelatti, U. es mtsai: Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am. J. Epidemiol., 2002, 155, 323-331.
9. Gronbaek, M., Becker, U., Johansen, D. es mtsai: Type of alcohol consumed and mortality from all causes, coronary heart disease and cancer. Ann. Intern. Med., 2000, 133, 411-419.
10. Becker, U., Gronbaek, M., Johansen, D. es mtsa: Lower risk for alcohol- induced cirrhosis in wine drinkers. Hepatology, 2002, 35, 868-875.
11. Wogan, G. N.: Afl atoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res., 1992, 52, 2114s-2118s.
12. Ross, R. K., Yuan, J. M., Yu, M. C. es mtsai: Urinary afl atoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 1992, 339, 943-946.
13. Bressac, B., Kew, M., Wands, J. es mtsa: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 1991, 350, 429-431.
14. Wang, L. Y., Chen, C. J., Zhang, Y. es mtsai: 4-aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am. J. Epidemiol., 1998, 147, 315-323.
15. Hassan, M. M., Spitz, M. R., Thomas, M. B. es mtsai: Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int. J. Cancer, 2008, 123, 1883-1891.
16. Caldwell, S. H., Crespo, D. M., Kang, H. S. es mtsa: Obesity and hepatocellular carcinoma. Gastroenterology, 2004, 127, S97-S103.
17. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. es mtsa: Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med., 2003, 348, 1625-1638.
18. Sanyal, A. J., Banas, C., Sargeant, C. es mtsai: Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology, 2006, 43, 682-689.
19. Ekstedt, M., Franzen, L. E., Mathiesen, U. L. es mtsai: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology, 2006, 44, 865-873.
20. El-Serag, H. B., Richardson, P. A., Everhart, J. E.: The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am. J. Gastroenterol., 2001, 96, 2462-2467.
21. El-Serag, H. B., Tran, T., Everhart, J. E.: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 2004, 126, 460-468.
22. Guzman, G., Brunt, E. M., Petrovic, L. M. es mtsai: Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch. Pathol. Lab. Med., 2008, 132, 1761-1766.
23. Donadon, V., Balbi, M., Casarin, P. es mtsai: Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J. Gastroenterol., 2008, 14, 5695-5700.
24. Roskams, T., Yang, S. Q., Koteish, A. es mtsai: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am. J. Pathol., 2003, 163, 1301-1311.
25. Yu, M. W., Hsieh, H. H., Pan, W. H. es mtsai: Vegetable consumption, serum retinol level and risk of hepatocellular carcinoma. Cancer Res., 1995, 55, 1301-1305.
26. Yu, M. W., Chiu, Y. H., Chiang, Y. C. es mtsai: Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms and risk of hepatocellular carcinoma: independent and interactive effects. Am. J. Epidemiol., 1999, 149, 621-629.
27. De, B. V., Welsh, J. A., Yu, M. C. es mtsa: P53 mutations in hepatocellular carcinoma related to oral contraceptive use. Carcinogenesis, 1996, 17, 145-149.
28. Yu, M. W., Yuan, J. M.: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology, 2004, 127, S72-S78.
29. Maheshwari, S., Sarraj, A., Kramer, J. es mtsa: Oral contraception and the risk of hepatocellular carcinoma. J. Hepatol., 2007, 47, 506-513.
30. Lindbohm, M. L., Sallmen, M., Kyyronen, P. es mtsai: Risk of liver cancer and exposure to organic solvents and gasoline vapors among Finnish workers. Int. J. Cancer, 2009, 124, 2954-2959.
31. Larsson, S. C., Wolk, A.: Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology, 2007, 132, 1740-1745. (Pubitemid 46677953)
32. Gressner, O. A.: Less Smad2 is good for you! A scientifi c update on coffee's liver benefi ts. Hepatology, 2009, 50, 970-978.
33. Abraldes, J. G., Albillos, A., Banares, R. es mtsai: Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology, 2009, 136, 1651-1658.
34. El-Serag, H. B., Johnson, M. L., Hachem, C. es mtsa: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology, 2009, 138, 1601-1608.